Skip to main content

Find Clinical Trials

Home
Conditions
Psoriasis Vulgaris

Clinical trial condition

Psoriasis Vulgaris

Explore clinical trials studying Psoriasis Vulgaris. Study availability and eligibility vary by location and protocol.

155 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Psoriasis Vulgaris trial results

Not Yet Recruiting

Pre-Post Multimodal Assessment Of Severe Psoriasis Vulgaris Using Clinical, Dermoscopic And QoL Measures

NCT07495657

Conditions: Psoriasis Vulgaris
Locations: Not specified

View Trial Details

Not Yet Recruiting

Topical Diacerein in Psoriasis Vulgaris

NCT07352306

Conditions: Psoriasis Vulgaris
Locations: Kasr Al-Ainy Psoriasis Unit Cairo, Egypt

View Trial Details

Not Yet Recruiting

Topical Thymoquinone in Psoriasis Vulgaris

NCT06508372

Conditions: Psoriasis Vulgaris
Locations: Not specified

View Trial Details

Not Yet Recruiting

Botox Versus Tacrolimus in Psoriasis Vulgaris

NCT06203470

Conditions: Psoriasis Vulgaris
Locations: Not specified

View Trial Details

Completed

Adjusted Brodalumab Dose Compared With Standard Brodalumab Dose in Subjects With Moderate-to-severe Plaque Psoriasis and ≥120 kg Body Weight

NCT04306315

Conditions: Psoriasis Vulgaris
Locations: LEO Pharma Investigational Site Brussels, Belgium

LEO Pharma Investigational Site Ham-sur-Heure-Nalinnes, Belgium

LEO Pharma Investigational Site Leuven, Belgium

LEO Pharma Investigational Site Liège, Belgium

View all 81 locations

View Trial Details

Completed

Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)

NCT03372811

Conditions: Psoriasis, Psoriasis Vulgaris, Skin Diseases, +3 more
Locations: Department of Dermatology, State University of New York, Downstate Medical Center New York, United States

Dermatology Associates Seattle, Washington, United States

View Trial Details

Completed

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

NCT04340076

Conditions: Psoriasis, Psoriasis Vulgaris, Skin Diseases, +2 more
Locations: ULB Erasme Brussels, Belgium

Ghent University Hospital Ghent, Belgium

AZ Maria Middelares Ghent, Belgium

AZ St Lucas Ghent, Belgium

View all 19 locations

View Trial Details

Completed

Topical SGX302 for Mild-to-Moderate Psoriasis

NCT05442190

Conditions: Plaque Psoriasis, Psoriasis, Psoriasis Vulgaris, +3 more
Locations: Therapeutics Clinical Research San Diego, California, United States

View Trial Details

Completed

Dermatologic Research Evaluation and Monitoring of Sleep in Moderate-to-Severe Psoriasis

NCT05102474

Conditions: Psoriasis Vulgaris
Locations: UCSF Psorisis Center San Francisco, California, United States

View Trial Details

Completed

A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

NCT06191042

Conditions: Arthritis, Arthritis, Psoriatic, Bone Diseases, +12 more
Locations: selectION Clinical Trial Site Bad Bentheim, Germany

selectION Clinical Trial Site Berlin, Germany

selectION Clinical Trial Site Blankenfelde-Mahlow, Germany

selectION Clinical Trial Site Hamburg, Germany

View Trial Details